Print

HVTN 092

Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults

Trial Details:

I Ongoing
National Institute of Allergy and Infectious Diseases, HIV Vaccine Trials Network (HVTN), EuroVacc, IPPOX, BMGF
DNA-HIV-PT123,NYVAC-HIV-PT1,NYVAC-HIV-PT4 DNA gag, env, nef, pol C; Pox Env gp140, Gag, Pol-Nef C
DNA-HIV-PT123 DNA
NYVAC-HIV-PT1 Viral Vector - Pox
NYVAC-HIV-PT4 Viral Vector - Pox
USA, Switzerland 209
NCT01783977
http://www.clinicaltrials.gov/ct2/show/NCT01783977